Differential expression of galectin-3, β-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands

Journal of Oral Pathology and Medicine

Volumn 38, Issue 9, 2009, Pages 701-707

  Ferrazzo, K L ^a,c   Neto, M M ^b   Dos Santos, E ^a   Dos Santos Pinto, D ^a   De Sousa, S O M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c Hospital Universitario   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; GALECTIN 3;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER GRADING; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; POLYMORPHOUS LOW GRADE ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALIVARY GLAND CARCINOMA; TUMOR CELL;

EID: 70350334600     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00776.x     Document Type: Article

References (30)

1. Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumors:pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 221-224.
2. Rapidis AD, Givalos N, Gakiopoulou H, et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 2005; 41: 328-335
3. Spiers ASD, Esseltine DLW, Ruckdeschel JC, Davies JNP, Horton J. Metastatic adenoid cystic carcinoma of salivary glands: case reports and review of the literature. Cancer Control 1996; 3: 336-342
4. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995; 32: 619-626
5. Buchner A, Merrell PW, Carpenter WM. Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med 2007; 36: 207-214
6. Paleri V, Robinson M, Bradley P. Polymorphous lowgrade adenocarcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 163-169
7. Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 14 cases of a distinctive neoplasm. Cancer 1984; 53: 935-942
8. Beltran D, Faquin WC, Gallagher G, August M. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 2006; 64: 415-423
9. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 2002; 15: 687-691
10. Araújo VC, Sousa SOM, Carvalho YR, Araújo NS. Application of immunohistochemistry in the diagnosis of salivary gland tumors. Appl Immunohistochem Mol Morphol 2000; 8: 195-202.
11. Darling MR, Schneider JW, Phillips VM. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 2002; 38: 641-645
12. Ferrazzo KL, Alves SM Jr, Santos E, Martins MT, De Sousa SM. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Oral Oncol 2007; 43: 580-585
13. Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006; 1760: 616-635
14. Lin HM, Pestell RG, Raz A, Kim HR. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 2002; 21: 8001-8010
15. Zhou CX, Gao Y. Aberrant expression of b-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 2006; 16: 505-511
16. Angadi PV, Krishnapillai R. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103:e30-5.
17. Greer RO Jr, Said S, Shroyer KR, Varella-Garcia M, Weed SA. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol 2007; 43: 735-741
18. Shiratsuchi H, Nakashima T, Hirakawa N, et al. b-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression. Head Neck 2007; 29: 577-584
19. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711-1717
20. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the b-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-5527
21. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A. Galectin-3, a novel binding partner of b-catenin. Cancer Res 2004; 64: 6363-6367
22. Shimura T, Takenaka Y, Fukumori T, et al. Implication of galectin-3 in Wnt signaling. Cancer Res 2005; 65: 3535-3537
23. Weinberger PM, Adam B-L, Gourin CG, et al. Association of nuclear, cytoplasmic expression of galectin-3 with b-catenin/Wnt-pathway activation in thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2007; 133: 503-510
24. Li SY, Davidson PJ, Lin NY, Patterson RJ, Wang JL, Arnoys EJ. Transport of galectin-3 between the nucleus and cytoplasm. II. Identification of the signal for nuclear export. Glycobiology 2006; 16: 612-622
25. Honjo Y, Inohara H, Akahani S, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000; 6: 4635-4640.
26. Bullions LC, Levine AJ. The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 1998; 10: 81-87
27. Lo Muzio L, Pannone G, Staibano S, et al. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res 2002; 22: 565-576
28. Ilyas M, Tomlinson IPM. The interactions of APC, E-cadherin and b-catenin in tumour development and progression. J Pathol 1997; 182: 128-137
29. Kim HR, Lin HM, Biliran H, Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 1999; 59: 4148-4154
30. Daa T, Kaku N, Kashima K, Nakayama I, Yokoyama S. Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland. J Exp Clin Cancer Res 2005; 24: 83-87.